Create an account or log in to participate in this activity
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston University Chobanian & Avedisian School of Medicine designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program meets the criteria of the Massachusetts Board of Registration in Medicine for 1.75 hours of risk management study.
This program meets the criteria of the Massachusetts Board of Registration in Medicine for 1.75 hours of opioid education.
In order to receive credit, participants must view the content of each module and complete the post-test and evaluation for each. Participants who receive a grade of 70% or greater on the post-tests will receive credit.
Both modules must be completed before credit will be awarded.
Physicians, nurse practitioners, physician assistants, and pharmacists.
At the conclusion of this activity, participants will be able to:
At the conclusion of this activity, participants will be able to:
Date of Original Release: January 6, 2014
Date of Most Recent Review: September 1, 2023
Date of Expiration: August 30, 2025
For questions about CME, please contact cme@bu.edu or www.bu.edu/cme.
To view Boston University’s Privacy Policy, please see http://www.bumc.bu.edu/cme/policies/.
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.
Daniel P. Alford, MD, MPH, FACP (Course Director)
Professor of Medicine
Boston University Chobanian & Avedisian School of Medicine
Boston Medical Center
Faculty member has no relevant financial relationships to disclose. Faculty member indicates that he does not discuss unlabeled/investigational uses of a commercial product.
dan.alford@bmc.org
Karen H. Seal, MD, MPH
San Francisco VA Medical Center and the University of California, San Francisco
Faculty member has no relevant financial relationships to disclose. Faculty member indicates that she does not plan to discuss unlabeled/investigational uses of a commercial product.
Emily Sachs, PhD
San Francisco VA Medical Center and the University of California, San Francisco
Faculty member has no relevant financial relationships to disclose. Faculty member indicates that she does not plan to discuss unlabeled/investigational uses of a commercial product.
Tracy Lin, PharmD
San Francisco VA Medical Center and the University of California, San Francisco
Faculty member has no relevant financial relationships to disclose. Faculty member indicates that she does not plan to discuss unlabeled/investigational uses of a commercial product.
William C. Becker, MD
Yale University and VA Connecticut Healthcare
Faculty member has no relevant financial relationships to disclose.
Ilana Hardesty, Program Operations Manager, Boston University Chobanian & Avedisian School of Medicine CCE, has no relevant financial relationships to disclose.
THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
This web-based activity is supported by the Substance Abuse and Mental Health Services Administration of the U.S. Department of Health and Human Services.
SCOPE of Pain
© 2024 Trustees of Boston University. Site by Root802.